Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-risk Melanoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06362369
What this trial is testing

Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy

Who this might be right for
Advanced CancerAdvanced Solid TumorMelanoma+15 more
7 Hills Pharma, LLC 126
Early research (Phase 1)Ended earlyNCT00629187
What this trial is testing

Safety Study of High Dose Temozolomide to Treat Relapsed/Refractory Central Nervous System (CNS) Malignancy

Who this might be right for
Central Nervous System NeoplasmsNeoplasm Metastasis
Tufts Medical Center 2
Early research (Phase 1)Study completedNCT02339324
What this trial is testing

Neoadjuvant Combination Biotherapy With Pembrolizumab and High Dose IFN-alfa2b

Who this might be right for
Melanoma
Yana Najjar 31
Early research (Phase 1)Study completedNCT02635672
What this trial is testing

Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer

Who this might be right for
Neoplasms
Vincerx Pharma, Inc. 110
Not applicableLooking for participantsNCT07092670
What this trial is testing

MELAFERT: Impact of Adjuvant Therapy on FERTility in Patients With Resected MELAnoma at High Risk of Relapse.

Who this might be right for
MelanomaFertility
Intergruppo Melanoma Italiano 270
Not applicableWithdrawnNCT00378781
What this trial is testing

Heparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related Infection

Who this might be right for
Cancer
M.D. Anderson Cancer Center
Large-scale testing (Phase 3)Ended earlyNCT04277663
What this trial is testing

The Study of IBI310 in Combination With IBI308 Compared to High-Dose Interferon In Patients With Acral Melanoma That Has Been Removed by Surgery

Who this might be right for
Acral Melanoma That Has Been Removed by Surgery
Innovent Biologics (Suzhou) Co. Ltd. 136
Testing effectiveness (Phase 2)Study completedNCT01993719
What this trial is testing

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
National Cancer Institute (NCI) 33
Testing effectiveness (Phase 2)WithdrawnNCT05496192
What this trial is testing

Nivolumab Intravenous (IV) to Subcutaneous (SC) Switch in Adjuvant Melanoma and Bladder Cancer

Who this might be right for
MelanomaUrothelial Carcinoma
Bristol-Myers Squibb
Testing effectiveness (Phase 2)Study completedNCT01124734
What this trial is testing

High Dose Interleukin-2 Followed by Intermittent Low Dose Temozolomide in Patients With Melanoma

Who this might be right for
Malignant Melanoma
Milton S. Hershey Medical Center 17
Not applicableUnknownNCT05062096
What this trial is testing

Characterization of NK Cells Under First Line Advanced Therapy Either as Curative Therapy for Metastatic Melanoma or as Adjuvant Therapy for High-risk of Recurrence

Who this might be right for
Melanoma
Assistance Publique - Hôpitaux de Paris 220
Testing effectiveness (Phase 2)Ended earlyNCT01814046
What this trial is testing

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Ocular Melanoma

Who this might be right for
Metastatic Ocular MelanomaMetastatic Uveal Melanoma
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Looking for participantsNCT05592626
What this trial is testing

A Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsGenital Neoplasm, FemaleUrogenital Neoplasms+11 more
Marengo Therapeutics, Inc. 366
Not applicableLooking for participantsNCT06298734
What this trial is testing

High-Intensity Exercise and High-Fiber Diet for Immunotherapy Outcomes in Melanoma Patients: The DUO Trial

Who this might be right for
Melanoma (Skin)Skin CancerAdvanced Melanoma
Fred Hutchinson Cancer Center 40
Large-scale testing (Phase 3)Active Not RecruitingNCT03553836
What this trial is testing

Safety and Efficacy of Pembrolizumab Compared to Placebo in Resected High-risk Stage II Melanoma (MK-3475-716/KEYNOTE-716)

Who this might be right for
Melanoma
Merck Sharp & Dohme LLC 976
Testing effectiveness (Phase 2)Ended earlyNCT02796352
What this trial is testing

A Phase II Study of High Dose Bolus IL2 in Patients With Inoperable Stage III or Stage IV Melanoma Who Have Failed Prior Anti-PD1 Immunotherapy: Efficacy and Biomarker Study

Who this might be right for
Melanoma
Ahmad Tarhini 1
Not applicableLooking for participantsNCT07206017
What this trial is testing

Explorative Study on Addition of High-fiber Dried Chicory Root in Patients With an Intermediate to High-risk Cutaneous Melanoma.

Who this might be right for
Melanoma, Stage II
University Medical Center Groningen 20
Large-scale testing (Phase 3)Study completedNCT01259934
What this trial is testing

Nordic Adjuvant IFN Melanoma Trial

Who this might be right for
MelanomaAdjuvant Therapy
Karolinska Institutet 855
Testing effectiveness (Phase 2)Ended earlyNCT04455503
What this trial is testing

Study of Adjuvant Immunotherapy With EVX-02 and Anti-PD-1

Who this might be right for
Melanoma Stage IVMelanoma Stage III
Evaxion Biotech A/S 15
Large-scale testing (Phase 3)UnknownNCT03435302
What this trial is testing

HDI Versus Chemotherapy as Systemic Adjuvant Therapy for Resected Mucosal Melanoma

Who this might be right for
Melanoma
Peking University Cancer Hospital & Institute 204
Next Page